pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 3·1 min read
save

Rising AI battle between hospitals and insurers drives soaring medical bills, says pediatric cardiologist

Jun 3, 2026·read at STAT ↗Negative

Darshak Sanghavi, a pediatric cardiologist and chief medical officer of Machinify, writes an opinion piece about an emerging AI conflict between health providers and insurers over patient records and billing.

He recounts a personal story of a newborn who required intensive care and resulted in a hospital bill of more than $550,000, highlighting the financial burden that can follow even life‑saving care.

Sanghavi warns that both hospitals and insurers are now training artificial‑intelligence systems to claim, verify, and contest the same medical data, creating an arms race that could further inflate costs and complicate reimbursement for patients and providers alike.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: The medical-billing AI arms race between providers and insurance”

read at STAT ↗
2,200 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE3LEADING
drugs
ObesityPLUVICTOlutetium Lu 177 vipivotide tetraxetan
topics
Cardiology2Oncology2HematologyInfectious DiseaseObesityPulmonologyRadioligand Therapy

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 15h ago‘Tactical athletes’ get new guidance for cardiovascular fitnessSTAT
  • 17h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • May 5The Type of Fat—Not the Amount—Fuels Pancreatic Canceronclive